n.achebe
TL2 Moderator · Verona
Contributes reviews on supplier material. Based in Verona.
Joined 24 December 2024 · last posted 5d
78Posts here
3Topics
1Solutions
262Likes received
135Likes given
21Badges
129Days visited
1.2kPosts read
Most-liked posts
-
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #27 · Data & Tools › Datasets · 17 Feb 2026 · 33 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Reading SURMOUNT-1 without the press release — one year on Replied, post #46 · Compounds › Tirzepatide · 10 Feb 2026 · 32 likes post #45 answers the question as asked. The question underneath it is different. The 2.5 mg starting dose is not a therapeutic dose in the sense that weight loss is…
-
Lean mass preservation: what the evidence supports — does this still hold? Replied, post #5 · Outcomes › Body composition · 22 Dec 2025 · 31 likes Comparison to published data: the trials reported mean fat and lean mass changes. Individual results vary around that mean. Being above or below average is not a sign…
-
Splitting a vial for two laboratories: how to do it without ruining both — what changed… Replied, post #32 · Sourcing › Independent verification · 2 Sep 2024 · 31 likes How to submit a sample: contact the service directly. They will provide instructions on vial type, quantity, labelling, shipping. Following their instructions exactly…
-
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #135 · Compounds › Tirzepatide · 22 May 2026 · 30 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Named, unnamed and unspecified impurities as regulatory categories — the long version Replied, post #67 · Analytics › Impurities & related substances · 11 Jul 2026 · 29 likes On post #63 — agreed on the reasoning, with one qualification. Truncation products: fragments from incomplete synthesis or from degradation. They elute quite…
Where this member posts
Badges earned, in order
| Badge | Tier | Granted |
|---|---|---|
| First Reply | bronze | 25 Dec 2024 |
| Read the Guidelines | bronze | 26 Dec 2024 |
| Basic User | bronze | 28 Dec 2024 |
| Welcome | bronze | 28 Dec 2024 |
| First Link | bronze | 29 Dec 2024 |
| Asked Well | bronze | 5 Jan 2025 |
| First Quote | bronze | 7 Jan 2025 |
| First Topic | bronze | 11 Jan 2025 |
| Member | bronze | 3 Feb 2025 |
| Sourced | bronze | 23 Feb 2025 |
| First Tag | bronze | 4 Mar 2025 |
| Editor | bronze | 13 Mar 2025 |
| First Solution | bronze | 6 Apr 2025 |
| Popular Link | silver | 7 Apr 2025 |
| Welcoming | silver | 9 Apr 2025 |
| Reader | bronze | 16 Apr 2025 |
| Nice Post | bronze | 19 May 2025 |
| Nice Topic | bronze | 24 Jun 2025 |
| Good Post | silver | 14 Jul 2025 |
| Anniversary | silver | 24 Dec 2025 |
| De-escalator | gold | 31 Jan 2026 |